Through its numerous programmes, Project Rosemary delivers sought-after, specialist education across the healthcare industry to upskill and empower professionals, with a key focus on service improvement.
The company collaborates with subject-matter experts and thought leaders, ensuring that its training is continually incorporating up-to-date information, methodologies and innovation to promote operational excellence.
To complement its core programmes, the business offers continuing education resources, clinical consultancy, research support and community engagement.
Read More
The company retains considerable scope to expand its offering by integrating content for other fields and introducing new solutions to enhance its influence over the wider healthcare education market.
Our clients are now offering the company for sale to facilitate further expansion using the resources of a new owner. Offers invited.
Key Highlights
– Programmes delivered via in-person and virtual formats; circa 17,000 attendees and 280+ events since the business’s inception.
– 340 active clients, including prominent, blue-chip entities and healthcare organisations.
– Target audience comprises doctors, nurses, allied health professionals, pharmacists, researchers, students, service managers, commissioners, ICB / ICS leads, primary care HCPs, and the third sector.
– Strong digital presence underpins the webinar activities. Between 2020 and 2024, the company had 17,000+ webinar registrations, 64,000+ recording views, and 1.5m+ website page views.
– Over 6,000 healthcare professionals / decision-makers subscribe to receive communications.
– Operates internationally, delivering education content throughout the UK, ROI, Canada, Asia and Australasia.
– Multi-skilled team that possesses a wealth of knowledge, experience and qualifications.
– Operates from leasehold office premises, though could be relocated.
Financial Highlights
– Generated a YE23 turnover of £1.34m, with an adjusted EBITDA of circa £220k.
– Forecast to achieve a YE25 turnover of £1.39m and adjusted EBITDA in excess of £400k.
– Average gross profit margin of 67% between YE20 and YE24.
– Over 93% of the income derives from contractual agreements, safeguarding the company’s revenue and strengthening partnerships. Most of the contracts run for individual financial years; however, the business has retained long-standing relationships with prominent clients that span over eight years.
– Allocated £175k in funding to introduce new initiatives for nurses and healthcare professionals.
– Recently onboarded a new client in a existing therapy area that has not been previously received funding; initial contract worth £30k+.
